Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADDUCE WP8 cardiovascular study of long-term methylphenidate use in adolescents and adults with ADHD
2013-004776-35Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: 24-hour ambulatory blood pressure and Left ventricular mass / hypertrophy by echocardiography. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2013-004776-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004776-35.